We analyzed data from twins to determine how much the familial risk of colorectal cancer can be attributed to genetic factors vs environment. We also examined whether heritability is distinct for colon vs rectal cancer, given evidence of distinct etiologies.
RESULTS:
From earliest registration in 1943 through 2010, there were 1861 individuals diagnosed with colon cancer and 1268 diagnosed with rectal cancer. Monozygotic twins of affected co-twins had an FRR for colorectal cancer of 3.1 (95% confidence interval [CI], 2.4-3.8) relative to the cohort risk. Dizygotic twins of affected co-twins had an FRR for colorectal cancer of 2.2 (95% CI, 1.7-2.7). We estimated that 40% (95% CI, 33%-48%) of the variation in colorectal cancer risk could be attributed to genetic factors; unique environment only accounted for the remaining liability. For colon cancer, the FRR was 3.3 (95% CI, 2.1-4.5) for monozygotic twins and 2.6 (95% CI, 1.7-3.5) for dizygotic twins. For rectal cancer, comparable estimates were 3.3 (95% CI, 1.5-5.1) for monozygotic twins and 2.6 (95% CI, 1.2-4.0) for dizygotic twins. Heritability estimates for colon and rectal cancer were 16% (95% CI, 0-46%) and 15% (95% CI, 0-50%), common environment estimates were 15% (95% CI, 0-38%) and 11% (95% CI, 0-38%), and unique environment estimates were 68% (95% CI, 57%-79%) and 75% (95% CI, 61%-88%), respectively.
See editorial on page 1204.
I
ndividuals with a first-degree relative affected by colorectal cancer have a 2-to 3-fold increased risk of disease themselves. 1 Although roughly 20% of colorectal cancer patients have an affected relative, less than 10% of colorectal cancers are inherited in an autosomal-dominant manner. 2 Familial clustering occurs even in the absence of defined Mendelian syndromes, 3 suggesting a potential role for inherited risk loci with low penetrance. Common risk loci explain up to 8% of colorectal cancer heritability, 4 and the more than 50 susceptibility variants that have been identified by genomewide association studies (summarized by Schmit et al 5 ) explain only 1% to 4% of the underlying genetic variation. 6 How much the remaining familial risk can be attributed to unknown heritable factors or environment remains unclear.
Prior twin studies of colorectal cancer have yielded heritability estimates between 9% and 35%. 7, 8 More recently, our group used methods that account for censoring and the competing risk of death, and we estimated heritabilities of colon and rectal cancer to be 15% and 14%, respectively. 9 Given discrepancies across prior estimates, we aimed to estimate colorectal cancer heritability in total as well as proximal colon, distal colon, and rectal cancer heritability separately, and to investigate differences in heritability across sex and age. In support of these objectives, we estimated the cumulative incidence of the cancers of interest among monozygotic (MZ) and dizygotic (DZ) twins using the Nordic Twin Study of Cancer.
Materials and Methods

The Population-Based Twin Cohorts
The Nordic Twin Study of Cancer cohort aggregates the population-based twin registries from Denmark, Finland, Norway, and Sweden, and their respective national cancer and mortality registries. Follow-up evaluation for cancer incidence essentially is complete. For this study, we excluded twins of unknown zygosity (n ¼ 57,057) and opposite-sex twins (n ¼ 96,499). Analyses were based on 203,690 twins. The Supplementary Materials and Methods contain additional information about the cohort.
The ethical committees of each country approved this study.
Definitions
Heritability is defined as the proportion of variability in disease risk caused by genetic factors. Familial risk is defined as the risk of disease in a twin, given an affected co-twin. This estimate relative to the overall population risk (ie, the familial risk ratio [FRR]) estimates excess familial risk in twins compared with the general population. Differences in familial risks by zygosity help ascertain the contribution of genetic vs nongenetic familial (ie, shared environmental exposures) factors on disease risk.
Statistical Analysis
The statistical analyses we used have been described elsewhere. 10 Briefly, we estimated the overall and sexspecific risks of total colorectal cancer, colon cancer (as well as proximal and distal colon cancer), and rectal cancer using the Aalen-Johansen estimator. 11 For each cancer subtype, we then analyzed heritability and familial risk for same-sex twin pairs. In estimating the cumulative incidence, we accounted for left-censoring owing to variable initiation of cancer registration. For all estimates, we accounted for right-censoring resulting from the end of follow-up evaluation and competing risk of death. 12, 13 We obtained familial risks by age and FRRs in MZ and DZ pairs separately.
14, 15 We tested the similarity of familial risk curves for MZ and DZ pairs by age using Pepe and Mori's test, 13 which has been shown to be the most powerful among various tests when evaluated in a similar setting. 16 We assessed the magnitude of genetic vs environmental influences on disease using quantitative models, decomposing the variation into the following components: additive genetic (A), dominant genetic (D), common (ie, shared) environmental (C), and unique (ie, nonshared) environmental (E) effects. 12, 13, [17] [18] [19] Because all 4 components cannot be estimated simultaneously owing to statistical issues, 18 a series of models are tested sequentially for the significance of specific parameters. Dominance effects are typically biologically implausible in the absence of additive effects, so the primary models are ACE and ADE, and their submodels AE and CE.
We assessed zygosity differences in disease prevalence by testing for equality of thresholds in MZ and DZ pairs. To test for variation in heritability by age at diagnosis, we estimated within-pair correlations for MZ and DZ pairs and the cumulative heritability of each cancer at each age. We then estimated differences in age at diagnosis within pairs as well as the mean and median differences in age at diagnosis for pairs in which both twins were diagnosed.
We investigated the colon and rectal cancer concordance relative risk to evaluate possible pleiotropy for colon and rectal cancer. At each age at which a twin was diagnosed with colon cancer whose co-twin already had been diagnosed with rectal cancer, or vice versa, we calculated the concordance risk. We then divided it by the marginal cumulative incidence of colon and rectal cancer. A relative risk of 1 would suggest that colon and rectal cancer are independent diagnoses, whereas relative risks greater than 1 would suggest familiality.
All statistical analyses were conducted using the package mets 1.1.0 (Copenhagen, Denmark) for R 3.1.3 (Vienna, Austria). 13 All tests were 2-sided with a P value less than .05 considered statistically significant.
Results
Among 203,690 same-sex twins, 3094 were diagnosed with colorectal cancer during follow-up evaluation (Table 1) . Roughly half of colorectal cancers occurred in males, and approximately three-fifths originated from the colon. Among 1532 colon cancers that could be classified further by subsite, just over half were proximal. There were 60 twin pairs (31 MZ and 29 DZ) concordant for colorectal cancer but discordant for colon or rectal subsite. Among 40 twin pairs (22 MZ) concordant for colon cancer with proximal vs distal information, 12 pairs (6 MZ) were discordant for subsite. Figure 1 shows the cumulative incidence of colorectal cancer by subsite, sex, country, and zygosity. The lifetime risk of colon cancer was 2.7% and that of rectal cancer was 1.8% ( Figure 1A ). Stratification by colon cancer subsite showed that the lifetime risk of proximal disease (1.0%) was slightly higher than that of distal disease (0.69%). The lifetime risk of colorectal cancer was similar across sexes (4.8% for men vs 4.4% for women) ( Figure 1B ); women were slightly more likely to be diagnosed with colon cancer (2.6% for men vs 2.8% for women), whereas rectal cancer was more common among men (2.2% for men vs 1.4% for women). The cumulative incidence of colorectal cancer overall was slightly higher in Denmark and Norway than in Sweden and Finland ( Figure 1C ). Estimates of cumulative incidence were similar among MZ and DZ twins ( Figure 1D ). Supplementary Table 1 shows within-pair concordances for vital status at the end of the follow-up evaluation for each cancer subsite. Table 2 presents the cancer subsite-specific results for lifetime risk of disease, familial risks by zygosity, and estimates of the genetic, common, and unique environmental variance components underlying variation in disease liability. Because models without dominant genetic effects best fit the data and we favored consistency in interpretation, we present estimates from ACE models only. If alternative models had a better fit, we indicate them in the text. There were some minor violations of the equal thresholds assumption in MZ and DZ pairs, noted in Supplementary Table 2 , but models run without the assumption returned materially unchanged results (data not shown). Supplementary Table 3 provides estimates from AE and CE submodels, and Supplementary Table 4 provides relative fit statistics for all models.
The overall lifetime risk of colorectal cancer was 4.6% and the familial risk was 18.1% among MZ and 9.9% among DZ twins. The FRR of colorectal cancer was 3.1 (95% confidence interval [CI], 2.4-3.8) for MZ and 2.2 (95% CI, 1.7-2.7) for DZ twins. Estimates of the proportion of disease variance based on the ACE model were 40% (95% CI, 33%-48%) for heritability and zero for common environment; the AE model best fit the data. Sex-stratified analyses yielded evidence that genetic effects explain more variation in disease liability in females than males. Specifically, heritability under the ACE model among women was estimated at 45% (95% CI, 35%-55%) and common environment did not contribute to variation in disease liability. For men, heritability was estimated at 28% (95% CI, 0%-61%) and common environment at 7% (95% CI, 0%-30%). The best-fitting models for males and females, respectively, were AE and ACE. The lifetime risk of colon cancer was 2.7% overall and the familial risk was 10.6% among MZ and 7.8% among DZ twins. The FRR of colon cancer was 3.3 (95% CI, 2.1-4.5) for MZ and 2.6 (95% CI, 1.7-3.5) for DZ twins. Quantitative modeling estimated heritability at 16% (95% CI, 0%-46%) and common environment at 15% (95% CI, 0%-38%). Again there was evidence of greater heritability among women (40%; best-fit model was AE) than men (0%; best-fit model was CE); precision of the estimates, however, was limited. The familial risks for proximal colon cancer (MZ, 10.9%; DZ, 4.8%) exceeded their counterparts for distal colon cancer (MZ, 6.6%; DZ, 2.5%). Estimates of heritability for both subsites, however, were 38% with an AE best-fit model. Findings from exploratory analyses of the sex-specific heritability of proximal and distal colon cancer suggested that heritability was larger among females for both subsites, particularly for proximal colon cancer (data not shown).
The lifetime risk of rectal cancer was 1.8% overall, and the familial risks were 6.4% and 4.6% for MZ and DZ twins, respectively. The FRR of rectal cancer was 3.3 (95% CI, 1.5-5.1) for MZ and 2.6 (95% CI, 1.2-4.0) for DZ twins. Heritability accounted for 15% (95% CI, 0%-50%) of the variation in liability whereas common environment explained 11% (95% CI, 0%-38%). Once again, there was a clear difference in the estimates by sex; heritability was estimated at 24% for women with an AE best-fit model and 8% for men with a CE best-fit model, again with limited precision. Figure 2 presents the familial risk of colorectal cancer across the lifespan. At every age, the risk of colorectal cancer for DZ twins of affected co-twins was higher than the overall risk in the twin population (ie, the marginal estimate). The risk for MZ twins of affected co-twins was higher than the corresponding risk for DZ twins (P diff < .001). The relative magnitude of familial risks for MZ vs DZ twins was largely consistent starting at age 65 for both male and female twin pairs, even though absolute risks increased over time.
Among concordant twin pairs, the mean times between diagnoses of colorectal cancer were 10.5 years (SE, 1.0) for MZ pairs and 9.9 years (SE, 1.1) for same-sex DZ pairs (P diff ¼ .70). Corresponding median times were 9.3 years for MZ pairs and 6.1 years for same-sex DZ pairs (P diff ¼ .21). Estimates of mean and median times between diagnoses for twin pairs concordant for colon cancer and, separately, rectal cancer, showed no significant differences by zygosity (data not shown). Figure 3 shows the cumulative heritability for colorectal cancer liability by 5-year intervals of age at diagnosis as derived from the quantitative modeling. Within-pair correlations remained relatively constant across the lifespan for both MZ and DZ pairs. The type and magnitude of the genetic and common environmental contribution did not change appreciably with increasing age. Figure 4 shows the concordance relative risks of colon and rectal cancer for 32 MZ pairs ( Figure 4A ), and 28 DZ pairs ( Figure 4B ) in which 1 twin was diagnosed with colon cancer and the other was diagnosed with rectal cancer. Individuals with co-twins who developed colon cancer had a substantial excess risk of developing rectal cancer, and vice versa, particularly at younger ages. Excess risks were especially apparent for MZ twin pairs.
Discussion
We found that twins of affected co-twins were at a substantially increased risk of colorectal cancer relative to the general population. We also found that genetic factors explain two fifths of the variation in liability to Among pairs with complete follow-up evaluation (ie, those for which both twins were diagnosed with cancer or died); discordant twin pairs with censoring are not counted because it is unknown whether they would have become concordant. b Based on the concordances in MZ and DZ pairs (and potentially lack of power), there is no indication of common environment and the model sets the common environmental component to zero. the disease. Heritability was greater among women than men, and greatest when colorectal cancer combining all subsites together was analyzed. The concordance relative risk for colon and rectal cancer was higher for MZ than DZ twins, suggesting that colon and rectal cancer may share inherited genetic risk factors. Screening endoscopy has been shown to prevent against colorectal cancer occurrence and deaths. 20 Twins of affected co-twins might benefit particularly from diligent screening given their excess risk relative to the general population. They also especially might benefit from colonoscopy over sigmoidoscopy; although both screening tests are valuable with respect to distal colon and rectal cancer, only colonoscopy has been shown to reduce proximal colon cancer risk and mortality. 20 Clinicians bear a large part of responsibility in determining screening practices. They might consider that twins of affected co-twins, and even siblings (who are as genetically similar as dizygotic twins) of affected individuals, should be encouraged to undergo routine screening. A complete family history is of utmost importance and may help guide decisions regarding screening methods and intervals.
Colorectal cancer heritability was estimated previously at 35% within the twin cohorts. 8 More recently, these analyses were updated with larger sample sizes, longer follow-up periods, and more robust statistical methods, and estimates of colon (15%) and rectal (14%) cancer heritability separately were lower. 9 Our results for colon and rectal cancer heritability were comparable, despite using a slightly different cohort subset. Our heritability estimate of 40% for total colorectal cancer is consistent with the Lichtenstein findings, 8 and lacking censoring or competing risk of death, our methods would have been comparable. 17, 18 However, our study was less prone to bias because we accounted for censoring and the competing risk of death. It also included more than 3 times the number of twin pairs, an additional 10 years of follow-up evaluation, the Norwegian cohort, and thus more than 2300 additional colorectal cancer cases. We thus were able to examine proximal colon, distal colon, and rectal cancer heritability separately, which is key given accumulating evidence that their etiologies and familial risks may be distinct. [21] [22] [23] Figure 3. Cumulative heritability in liability to colorectal cancer by 5-year intervals of age at diagnosis, modeling heritability, and common and unique environmental components of liability to disease, adjusted for censoring using inverse probability weighting. There are thought to be 3 primary tumorigenic pathways in colorectal carcinogenesis: chromosomal instability, microsatellite instability, and CpG island methylator phenotype. 24 Chromosomal instability seems to be the predominant mechanism in distal colon and rectal carcinogenesis, 25, 26 whereas the overlapping microsatellite instability and CpG island methylator phenotype pathways more often predispose to proximal colon cancers. 27, 28 The latter 2 pathways also more often are implicated in hereditary cancer, 26, [29] [30] [31] and family history seems associated most strongly with sporadic proximal colon cancer. 21, 23 The sum of these parts renders it somewhat surprising that our results did not more strongly suggest that proximal colon cancer is more heritable than distal colon cancer and that colon cancer overall is more heritable than rectal cancer. The ACE models did not indicate such relative magnitudes of heritability, although models that excluded the common environment component were more indicative of the expected results. Notably, a previous family study from Sweden also found that colon and rectal cancer were roughly equally heritable. 32 Heritability estimates were greater for colorectal cancer overall than for colon or rectal cancer individually. These differences could reflect limited power, but also could indicate shared genetic factors contributing to both sites. That the concordance relative risk for colon and rectal cancer was higher for MZ than DZ twins supports the latter explanation. This finding is interesting given that several lifestyle and dietary factors have been associated differentially with colon and rectal cancer. 23, 33 Although a small number of genetic variants has a substantial effect on colorectal cancer, a considerable portion of its heritability is thought to result from multiple low-risk variants. 8, 34, 35 More than 50 have been identified as credibly associated with colorectal cancer risk (summarized by Schmit et al 5 ), but they account for a small proportion of heritability. 6 All common variants genome-wide only account for 8% of heritability. 4 It is likely that rare variants, other genetic variations, gene-gene interactions, and/or epigenetics contribute to the total heritability of colorectal cancer.
For all of the cancer sites we evaluated, heritability was larger among females than males. Chance could have played a role given the limited sample sizes of stratified analyses, but the results also could be attributable to an increased prevalence of lifestyle risk factors for colorectal cancer among men relative to women. For example, men in Nordic countries smoke tobacco 36 and drink alcohol 37 more than women. These behaviors tend to aggregate within families, 38, 39 so perhaps it is unsurprising that we see higher estimates for common environmental effects on liability to colorectal cancer among males than females. That the unique environmental components of disease liability were consistently higher for males than females also could have reduced the heritability components. If, however, environmental risk factors were to interact with genetic factors, then heritability could be either greater or lesser among men than women.
Our study included all cancers at the relevant sites, regardless of histology. We also were unable to exclude cancers attributable to hereditary syndromes; although these cases likely were rare, our estimates for sporadic cancer could be slightly skewed. We had limited power to distinguish heritable genetic from environmental effects, particularly in stratified analyses. For some models, we detected minor violations of the equal threshold assumption, but forced equality of the marginal risks for MZ and DZ twins. However, heritability estimates without the assumption were comparable, and observed differences in cumulative risk between MZ and DZ pairs were small. Our study also lacked information regarding colorectal cancer screening. Our analyses assumed that the probability of screening among cotwins was independent of zygosity. If, however, an MZ co-twin was more likely to be screened than a DZ cotwin of a diagnosed twin, then the genetic component of our analyses could have been biased. It seems unlikely that this would have been a sizable issue given that the study countries did not have national endoscopy screening programs during the study time frame, and that any consequential sporadic screening likely would not have started until well into the study period (ie, the 1980s).
In summary, colorectal cancer has a substantial heritable component and it may be more heritable in women than men. Given that the risk variants that have been discovered in genome-wide association studies thus far do not come close to accounting for the disease's heritability, there remain many genetic risk variants that have yet to be uncovered. Much research remains to be performed to explain the 40% of variation in colorectal cancer liability that we determined to be attributable to heritability.
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